Cue Biopharma
37 hedge funds and large institutions have $40.5M invested in Cue Biopharma in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
3% less funds holding
Funds holding: 38 → 37 (-1)
Holders
37
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.5M | |
| 2 | +$1.82M | |
| 3 | +$1.39M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$570K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$530K |
Top Sellers
| 1 | -$292K | |
| 2 | -$86K | |
| 3 | -$80.3K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$64.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$16K |